This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Learn how to choose a low-fee Dividend Aristocrats ETF and what fees to watch. This intro covers cost factors and quick tips for a cost-efficient selection.
24,603 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
The advanced micro devices stock staged a notable bounce after a period of pressure, driven by AI investment news and...
As Netflix stumbles, investors wonder if Disney down 2026 offers a rare contrarian opportunity. This article digs int...
The NASDAQ dipped after prosecutors charged a Super Micro Computer co-founder with aiding a $2.5 billion AI-server sh...
Micron stock has faced a pullback as market focus shifts from AI optimism to risk management. This article breaks dow...
As Amazon prepares for its next earnings release, a provocative scenario targets Andy Jassy and AWS. This piece break...
As the week nears its end, Thursday often brings a fresh wave of data and earnings that can move markets. This guide ...
AMD stock soared in May as AI-driven demand, data center expansion, and a refreshed product lineup converged to lift ...
Micron stock just dropped as traders weigh demand for memory parts against a backdrop of cyclical pricing. This artic...
Retail traders moved $5.4 trillion in 2025, a surge that upended old stereotypes and helped push markets in new direc...
As crude rises, bitcoin sinks to fresh multi-month lows. This article unpacks the connection between oil and crypto, ...
A memory stock that looked ordinary just a year ago has stunned investors with an 8x move. Now Wall Street is unanimo...